Italy: Detailed report of the new RNA vaccine

Dr. Loretta Bolgan and Corvelva prepared a detailed report of the new RNA vaccine that Moderna and Oxford University is developing. This publication contains accurate bibliographic materials and references on the efficacy and intrinsic risks peculiar to the type of pharmacological product (vaccines) currently being approved; it aims to be, at the same time, a guide in the literature currently available on the subject and a warning to those who have the institutional - as well as ethical - responsibility to guarantee the safety of pharmaceutical products administered to the population.

https://www.corvelva.it/en/speciale-corvelva/corvelva-ebook/covid-19-il-vaccino-che-verra.html